Page last updated: 2024-09-03

garenoxacin and Bacterial Pneumonia

garenoxacin has been researched along with Bacterial Pneumonia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mikamo, H; Mitsuyama, J; Nakagawa, S; Nomura, N; Shibata, T; Yamagishi, Y1
Fujita, J; Higa, F; Hiramatsu, K; Kadota, J; Kohno, S; Tateyama, M; Tokimatsu, I; Yamamoto, Y; Yanagihara, K1
Hosono, H; Ishida, T; Izumikawa, K; Kohno, S; Kushimoto, S; Miyashita, N; Watanabe, A2
Kobayashi, H; Takagi, H; Tanaka, K; Tsuda, H1
Fujii, T; Gonoi, T; Imai, K; Iwamoto, A; Kikuchi, T; Koga, M; Koibuchi, T; Miura, T; Nakamura, H; Yazawa, K1
Fukuda, Y; Futakuchi, N; Mitsuyama, J; Nomura, N; Shiokawa, Y; Sugiura, Y; Takahata, M1
Hammerschlag, MR; Reznik, T; Roblin, PM1
Fritsche, TR; Jones, RN; Sader, HS; Stilwell, MG1

Reviews

1 review(s) available for garenoxacin and Bacterial Pneumonia

ArticleYear
Clinical studies of garenoxacin.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clinical Trials, Phase III as Topic; Fluoroquinolones; Humans; Pneumonia, Bacterial

2008

Trials

1 trial(s) available for garenoxacin and Bacterial Pneumonia

ArticleYear
Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Pneumonia, Bacterial; Recurrence; Sulbactam; Treatment Outcome

2013

Other Studies

7 other study(ies) available for garenoxacin and Bacterial Pneumonia

ArticleYear
Proposed Pharmacokinetic-Pharmacodynamic Breakpoint of Garenoxacin and Other Quinolones.
    Japanese journal of infectious diseases, 2017, Nov-22, Volume: 70, Issue:6

    Topics: Administration, Oral; Anti-Bacterial Agents; Area Under Curve; Community-Acquired Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pneumonia, Bacterial; Quinolones; Streptococcus pneumoniae

2017
Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: postmarketing surveillance in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Chlamydophila Infections; Chlamydophila pneumoniae; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Product Surveillance, Postmarketing; Prospective Studies; Quinolines; Tablets

2014
Efficacy and safety of garenoxacin tablets on bacterial pneumonia: postmarketing surveillance in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:9

    Topics: Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Pneumococcal Infections; Pneumonia, Bacterial; Product Surveillance, Postmarketing; Prospective Studies; Quinolines; Streptococcus pneumoniae; Tablets

2014
Pulmonary nocardiosis caused by Nocardia exalbida complicating Pneumocystis pneumonia in an HIV-infected patient.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Fluoroquinolones; Humans; Male; Middle Aged; Nocardia; Nocardia Infections; Pentamidine; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Sputum; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination

2011
In vitro and in vivo antibacterial activities of garenoxacin against group G Streptococcus dysgalactiae subsp. equisimilis.
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Fluoroquinolones; Humans; Male; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus; Treatment Outcome

2011
In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae.
    International journal of antimicrobial agents, 2003, Volume: 21, Issue:6

    Topics: Adult; Anti-Infective Agents; Canada; Chlamydophila Infections; Chlamydophila pneumoniae; Community-Acquired Infections; Fluoroquinolones; Humans; Indoles; Japan; Microbial Sensitivity Tests; Pneumonia, Bacterial; Quinolones; United States

2003
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Diagnostic microbiology and infectious disease, 2007, Volume: 58, Issue:1

    Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Hospitalization; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Streptococcus pneumoniae

2007